M. M. Ilkovich
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 18
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Neonatal Respiratory Health Research 3
- Pulmonary Hypertension Research and Treatments 3
- Medical Imaging and Pathology Studies 3
-
- Sarcoidosis and Beryllium Toxicity Research 18
-
- Mast cells and histamine 2
-
- Drug-Induced Adverse Reactions 3
M. M. Ilkovich
23 papers receiving 146 citations
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 125
- Physiology 55
- Otorhinolaryngology 4
- Surgery 38
- Immunology 12
Countries citing papers authored by M. M. Ilkovich
This map shows the geographic impact of M. M. Ilkovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. M. Ilkovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. M. Ilkovich more than expected).
Fields of papers citing papers by M. M. Ilkovich
This network shows the impact of papers produced by M. M. Ilkovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. M. Ilkovich. The network helps show where M. M. Ilkovich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. M. Ilkovich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 59 | |
| 11 | 2020 | 5 | |
| 12 | 2019 | 0 | |
| 13 | 2019 | 0 | |
| 14 | 2018 | 0 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 1 | |
| 18 | 2014 | 10 | |
| 19 | 2014 | 2 | |
| 20 | 2012 | 1 |
About M. M. Ilkovich
M. M. Ilkovich is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology, having authored 28 papers that have together received 148 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Sarcoidosis and Beryllium Toxicity Research (18 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Drug-Induced Adverse Reactions (3 papers), Neonatal Respiratory Health Research (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Medical Imaging and Pathology Studies (3 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (125 citations), Physiology (55 citations) and Otorhinolaryngology (4 citations). M. M. Ilkovich has collaborated with scholars based in Russia, Czechia and France. Frequent co-authors include Арег А. Тотолян, Cecilia Ganslandt, Bruce C. Trapnell, Mordechai R. Kramer, Yoshikazu Inoue, Inge Tarnow, Cliff Morgan, Michael Kreuter, С. Н. Авдеев and Francesco Bonella.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.